FDA Adverse Event Malfunction Summary report: N

UNICEL DXI 800 ACCESS® IMMUNOASSAY SYSTEM

MDR report key: 2190020 · Received August 4, 2011

Report

Report Number
2122870-2011-02673
Event Type
Malfunction
Date Received
August 4, 2011
Date of Event
June 24, 2011
Report Date
July 1, 2011
Manufacturer
BECKMAN COULTER, INC.
Product Code
MMI
PMA / PMN Number
K023764
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PATIENT SAMPLE WAS COLLECTED IN A 13X100MM GREINER SERUM TUBE WITH A GEL SEPARATOR AND CENTRIFUGED FOR 10 MINUTES AT 3000G AT 20 DEGREES C. THE CUSTOMER STATED THAT THE SAMPLE WAS A HALF FULL TUBE AND WAS ANALYZED FROM AN ALIQUOT OF THE ORIGINAL SAMPLE. PER THE CUSTOMER, ACCUTNI QC HAD BEEN WITHIN THE CUSTOMER'S ESTABLISHED RANGES. SPECIFIC QC DATA WAS NOT PROVIDED BY THE CUSTOMER. THE CUSTOMER DID NOT PROVIDE SYSTEM INFORMATION. SERVICE WAS NOT DISPATCHED FOR THIS EVENT AS THE CUSTOMER WAS NOT QUESTIONING INSTRUMENT PERFORMANCE AT THIS TIME. A CLEAR ROOT CAUSE COULD NOT BE DETERMINED FOR THIS EVENT.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER, INC. (BEC) TO REPORT OBTAINING AN ERRONEOUSLY ELEVATED TROPONIN (ACCUTNI) RESULT WITHIN THE RISK STRATIFICATION RANGE FOR ONE (1) PATIENT. THE ELEVATED ACCUTNI RESULT WAS GENERATED ON A UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM, USED IN CONJUNCTION WITH ACCESS ACCUTNI REAGENT (LOT 110863). SUBSEQUENT TESTING ON THE SAME INSTRUMENT PRODUCED LOWER RESULTS WITHIN THE NORMAL REFERENCE RANGE. THE ELEVATED ACCUTNI RESULT WAS NOT REPORTED OUT OF THE LAB. THE CUSTOMER DID NOT RECEIVE ANY REPORT OF PATIENT INJURY REQUIRING MEDICAL INTERVENTION OR CHANGE TO PATIENT TREATMENT ATTRIBUTED OR CONNECTED TO THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL DXI 800 ACCESS® IMMUNOASSAY SYSTEM DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER FOR CLINICAL USE MMI BECKMAN COULTER, INC. DXI 800 NA

Patients

Seq Age Sex Outcome Treatment
1